Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 96 , Pages S3-S7 , April 2002

Mechanisms of pathogenesis: differences amongst Leishmania species

References 

  1. Afonso LC, Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infection and Immunity. 1993;61:2952–2959
  2. Beebe AM, Jauze S, Schork NJ, Coffman RL. Serial backcross mapping of multiple loci associated with resistance to Leishmania major infections. Immunity. 1997;6:551–557
  3. Blackwell JM. Genetic control of recovery from visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1982;76:147–157
  4. Blackwell JM. Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics. 1983;18:101–109
  5. Blackwell JM, Hale C, Roberts MB, Ulczak OM, Liew F-Y, Howard JG. An H-11 linked gene has a parallel effect on Leishmania major and L. donovani infections in mice. Immunogenetics. 1985;21:385–395
  6. Carvalho EM, Correia-Filho D, Bacellar O, Almedia RP, Lessa H, Rocha H. Characterization of the immune respnse in subjects with self-healing cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene. 1995;53:273–277
  7. Chakkalath HR, Theodos CM, Markowitz JS, Grusby MJ, Glimcher LH, Titus RG. Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. Journal of Infectious Disease. 1995;171:1302–1308
  8. Crocker PR, Davies EV, Blackwell JM. Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani. Parasite Immunology. 1987;9:705–719
  9. Da-Cruz AM, Conceição-Silva F, Bertho AL, Coutinho S. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infection and Immunity. 1994;62:2614–2618
  10. Davies EV, Singleton AM, Blackwell JM. Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations. Infection and Immunity. 1988;56:1128–1134
  11. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. European Journal of Immunology. 1998;28:669–680
  12. Esterre P, Dedet JP, Frenay C, Chevallier M, Grimaud JA. Cell populations in the lesions of human cutaneous leishmanasis; a light microscopical, immunohisto-chemical and ultrastructural study. Virchows Archiv, A: Pathology, Anatomy, and Histopathology. 1992;421:239–247
  13. Gomes NA, Gattass CR, Barreto-De-Souza V, Wilson ME, DosReis GA. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar. Journal of Immunology. 2000;164:2001–2008
  14. Groux H, Cottrez F, Rouleau M, Mauze S, Antonenko S, Hurst S, et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. Journal of Immunology. 1999;162:1723–1729
  15. Hill JO, Awwad M, North RJ. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania. Journal of Experimental Medicine. 1989;169:1819–1827
  16. Kaye PM, Curry AJ, Blackwell JM. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. Journal of Immunology. 1991;146:2763–2770
  17. Kaye PM, Rogers NJ, Curry AJ, Scott JC. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. European Journal of Immunology. 1994;24:2850–2854
  18. Kima PE, Soong L, Chicharro C, Ruddle NH, McMahon-Pratt DM. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells. European Journal of Immunology. 1996;26:3163–3169
  19. Kima PE, Constant SL, Hannum L, Colmenares M, Lee K, Haberman AM, et al. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. Journal of Experimental Medicine. 2000;191:1063–1067
  20. Li J, Hunter CA, Farrell JP. Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. Journal of Immunology. 1999;162:974–979
  21. Locksley RM, Wakil AE, Corry DB, Pingel S, Bix M, Fowell DJ. The development of effector T cell subsets in murine Leishmania major infection. In: Ciba Foundation Symposium. 195:1995;p. 110–117 [discussion on pp. 117–122]
  22. Louzir H, Melby PC, Ben Salah A, Marrakchi H, Aoun K, Ben Ismail R, et al. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. Journal of Infectious Diseases. 1998;177:1687–1695
  23. McElrath MJ, Kaplan G, Nusrat A, Cohn ZA. Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice. Journal of Experimental Medicine. 1987;165:546–559
  24. McElrath MJ, Murray HW, Cohn ZA. Dynamics of granuloma formation in experimental visceral leishmaniasis. Journal of Experimental Medicine. 1988;167:1927–1937
  25. McMahon-Pratt D, Rodriguez D, Rodriguez JR, Zhang Y, Manson K, Bergman C, et al. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infection and Immunity. 1993;61:3351–3359
  26. McSorley SJ, Xu D, Liew F-Y. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters. Infection and Immunity. 1997;65:171–178
  27. Murray HW. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. Journal of Infectious Diseases. 1997;175:1477–1479
  28. Murray HW, Hariprashad J, Coffman RL. Behaviour of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model. Journal of Experimental Medicine. 1997;185:867–874
  29. Palma GI, Saravia NG. In situ characterization of the human host response to Leishmania panamensis. American Journal of Dermatology. 1997;19:585–590
  30. Peters C, Aebischer T, Stierhorf YD, Fuchs M, Overath P. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. Journal of Cell Science. 1995;108:3715–3724
  31. Prina E, Liang T, Glaichenhaus N, Antoine JC. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. Journal of Immunology. 1996;156:4318–4322
  32. Rachamim N, Jaffe CL. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. Journal of Immunology. 1993;150:2322–2331
  33. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annual Review of Immunology. 1995;13:151–177
  34. Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. Journal of Experimental Medicine. 1997;85:1705–1710
  35. Roberts M, Mock BA, Blackwell JM. Mapping of genes conrolling Leishmania major infection in CXS recombinant inbred mice. European Journal of Immunogenetics. 1993;20:349–362
  36. Saha B, Nanda-Roy H, Pakrashi A, Chakrabarti RN, Roy S. Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis. European Journal of Immunology. 1991;21:577–581
  37. Scott P, Sacks D, Sher A. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis. Journal of Immunology. 1983;131:966–971
  38. Scott P, Natovitz P, Sher A. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. Journal of Immunology. 1986;137:1017–1021
  39. Semprevivo LH, DeTolla LJ, Passmore HC, Palczuk NC. Spectral model of leishmaniasis in congenic strains of mice. Journal of Parasitology. 1981;67:8–14
  40. Sher A, Sacks DL, Scott PA. Host and parasite factors influencing the expression of cutaneous leishmaniasis. In: Ciba Foundation Symposium. 99:1983;p. 174–189
  41. Smelt SC, Engwerda CR, McCrossen M, Kaye PM. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. Journal of Immunology. 1997;158:3813–3821
  42. Smelt SC, Cotterell SEJ, Engwerde CR, Kaye PM. B cell deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. Journal of Immunology. 2000;164:3681–3688
  43. Soong L, Duboise SM, Kima P, McMahon-Pratt D. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infection and Immunity. 1995;63:3559–3566
  44. Soong L, Chang CH, Sun J, Longley BJ, Ruddle NH, Flavell RA, et al. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. Journal of Immunology. 1997;158:5374–5383
  45. Stern JJ, Oca MJ, Rubin BY, Anderson SL, Murray HW. Role of L3T4+ and Lyt-2+ cells in experimental visceral leishmaniasis. Journal of Immunology. 1988;140:3971–3977
  46. Sundar S, Reed SG, Sharma S, Mehotra A, Murray HW. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene. 1997;56:522–525
  47. Tumang MCT, Keogh C, Moldawer LL, Hlfgott DC, Teitelbaum R, Hariprashad J, et al. The role and effect of TNF-α in experimental visceral leishmaniasis. Journal of Immunology. 1994;153:768–775
  48. Veress B, Omer A, Satir AA, El Hassan AM. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology. 1977;33:607–610
  49. Vidal S, Trembly ML, Govoni G, Gauthier S, Sevastiani G, Malo D, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp 1 gene. Journal of Experimental Medicine. 1995;182:655–666
  50. Wang ZE, Zheng S, Corry DB, Dalton DK, Seder RA, Reiner SL, et al. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. In: Proceedings of the National Academy of Sciences of the USA. 91:1994;p. 12932–12936
  51. Wilson ME, Sandor M, Blum AM, Young BM, Metwaldi A, Elliot D, et al. Local suppression of IFN-γ in hepatic granulomas correlates with tissue specific replication of Leishmania chagasi. Journal of Immunology. 1996;156:2231–2239
  52. Wilson ME, Young BM, Davidson BL, Mente KA, McGowan SE. The importance of TGF-beta in murine visceral leishmaniasis. Journal of Immunology. 1998;161:6148–6155

PII: S0035-9203(02)90044-1

Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume 96 , Pages S3-S7 , April 2002

Article Tools